Cell Reports (Feb 2022)

Transcriptome-wide changes in gene expression, splicing, and lncRNAs in response to a live attenuated dengue virus vaccine

  • Eun-Young Kim,
  • Yan Che,
  • Hansi J. Dean,
  • Ramon Lorenzo-Redondo,
  • Michael Stewart,
  • Caroline K. Keller,
  • Daniel Whorf,
  • Dawson Mills,
  • Nikita N. Dulin,
  • Tiffany Kim,
  • Megan Votoupal,
  • Miriam Walter,
  • Ana Fernandez-Sesma,
  • Heejin Kim,
  • Steven M. Wolinsky

Journal volume & issue
Vol. 38, no. 6
p. 110341

Abstract

Read online

Summary: The tetravalent dengue vaccine candidate, TAK-003, induces a functional antibody response, but the titers of antibodies against the four serotypes of the dengue virus (DENV) can vary. Here, through a transcriptomic analysis on whole blood collected from recipients of a two-dose schedule of TAK-003, we examine gene expression, splicing, and transcript isoform-level changes for both protein-coding and noncoding genes to broaden our understanding of the immune response. Our analysis reveals a dynamic pattern of vaccine-associated regulation of long noncoding RNAs (lncRNAs), differential splicing of interferon-stimulated gene exons, and gene expression changes related to multiple signaling pathways that detect viral infection. Co-expression networks isolate immune cell-type-related and interferon-response modules that represent specific biological processes that correlate with more robust antibody responses. These data provide insights into the early determinants of the variable immune response to the vaccine, highlighting the significance of splicing and isoform-level gene regulatory mechanisms in defining vaccine immunogenicity.

Keywords